# Claros Mortgage Trust, Inc.: financial statements, quarterly

CMTG · NYSE · CIK 1666291 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cmtg.md) · [Financials](/companies/cmtg/financials.md) · [Filings](/companies/cmtg/filings.md) · [Insiders](/companies/cmtg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cmtg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [80.6](/filings/0000950170-24-123247.md) | [76.0 d](/filings/0001193125-26-057455.md) | [58.8](/filings/0000950170-25-065829.md) | [64.5](/filings/0000950170-25-104004.md) | [64.9](/filings/0001193125-25-266902.md) | [60.2 d](/filings/0001193125-26-057455.md) | [43.4](/filings/0001193125-26-208946.md) | [51.6](/filings/0001193125-26-323733.md) | [46.1](/filings/0001193125-25-266902.md) | [46.7 d](/filings/0001193125-26-057455.md) | [29.5](/filings/0001193125-26-208946.md) | [29.7](/filings/0001193125-26-323733.md) |
| Interest expense | $m | [124](/filings/0000950170-24-123247.md) | [121 d](/filings/0001193125-26-057455.md) | [116](/filings/0000950170-25-065829.md) | [113](/filings/0000950170-25-104004.md) | [111](/filings/0001193125-25-266902.md) | [100 d](/filings/0001193125-26-057455.md) | [89.2](/filings/0001193125-26-208946.md) | [82.0](/filings/0001193125-26-323733.md) | [71.8](/filings/0001193125-25-266902.md) | [61.9 d](/filings/0001193125-26-057455.md) | [50.9](/filings/0001193125-26-208946.md) | [46.6](/filings/0001193125-26-323733.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(68.9)](/filings/0000950170-24-123247.md) | [34.0 d](/filings/0001193125-26-057455.md) | [(52.8)](/filings/0001193125-25-266902.md) | [(11.6)](/filings/0001193125-25-266902.md) | [(56.2)](/filings/0001193125-25-266902.md) | [(101) d](/filings/0001193125-26-057455.md) | [(78.6)](/filings/0001193125-26-323733.md) | [(182)](/filings/0001193125-26-323733.md) | [(9.5)](/filings/0001193125-25-266902.md) | [(219) d](/filings/0001193125-26-057455.md) | [(54.3)](/filings/0001193125-26-323733.md) | [(255)](/filings/0001193125-26-323733.md) |
| Diluted EPS | $ per share | [(0.50)](/filings/0000950170-24-123247.md) | not reported | [(0.39)](/filings/0000950170-25-065829.md) | [(0.09)](/filings/0000950170-25-104004.md) | [(0.40)](/filings/0001193125-25-266902.md) | not reported | [(0.56)](/filings/0001193125-26-208946.md) | [(1.30)](/filings/0001193125-26-323733.md) | [(0.07)](/filings/0001193125-25-266902.md) | not reported | [(0.39)](/filings/0001193125-26-208946.md) | [(1.81)](/filings/0001193125-26-323733.md) |
| Basic EPS | $ per share | [(0.50)](/filings/0000950170-24-123247.md) | not reported | [(0.39)](/filings/0000950170-25-065829.md) | [(0.09)](/filings/0000950170-25-104004.md) | [(0.40)](/filings/0001193125-25-266902.md) | not reported | [(0.56)](/filings/0001193125-26-208946.md) | [(1.30)](/filings/0001193125-26-323733.md) | [(0.07)](/filings/0001193125-25-266902.md) | not reported | [(0.39)](/filings/0001193125-26-208946.md) | [(1.81)](/filings/0001193125-26-323733.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [307](/filings/0000950170-24-123247.md) | [187](/filings/0001193125-26-057455.md) | [233](/filings/0000950170-25-065829.md) | [148](/filings/0000950170-25-104004.md) | [114](/filings/0001193125-25-266902.md) | [99.1](/filings/0001193125-26-057455.md) | [128](/filings/0001193125-26-208946.md) | [209](/filings/0001193125-26-323733.md) | [340](/filings/0001193125-25-266902.md) | [173](/filings/0001193125-26-323733.md) | [117](/filings/0001193125-26-208946.md) | [90.3](/filings/0001193125-26-323733.md) |
| Total assets | $m | [8,048](/filings/0000950170-23-056882.md) | [8,069](/filings/0000950170-25-023258.md) | [7,756](/filings/0000950170-24-053558.md) | [7,585](/filings/0000950170-24-090737.md) | [7,308](/filings/0000950170-24-123247.md) | [6,967](/filings/0001193125-26-057455.md) | [6,656](/filings/0000950170-25-065829.md) | [5,823](/filings/0000950170-25-104004.md) | [5,442](/filings/0001193125-25-266902.md) | [4,722](/filings/0001193125-26-323733.md) | [4,164](/filings/0001193125-26-208946.md) | [3,835](/filings/0001193125-26-323733.md) |
| Total liabilities | $m | [5,752](/filings/0000950170-23-056882.md) | [5,769](/filings/0000950170-25-023258.md) | [5,540](/filings/0000950170-24-053558.md) | [5,413](/filings/0000950170-24-090737.md) | [5,204](/filings/0000950170-24-123247.md) | [4,959](/filings/0001193125-26-057455.md) | [4,722](/filings/0000950170-25-065829.md) | [4,066](/filings/0000950170-25-104004.md) | [3,693](/filings/0001193125-25-266902.md) | [3,190](/filings/0001193125-26-323733.md) | [2,672](/filings/0001193125-26-208946.md) | [2,597](/filings/0001193125-26-323733.md) |
| Long-term debt | $m | [5,667](/filings/0000950170-23-056882.md) | [5,694](/filings/0000950170-25-023258.md) | [5,468](/filings/0000950170-24-053558.md) | [5,340](/filings/0000950170-24-090737.md) | [5,143](/filings/0000950170-24-123247.md) | [4,900](/filings/0001193125-26-057455.md) | [4,684](/filings/0000950170-25-065829.md) | [4,032](/filings/0000950170-25-104004.md) | [3,656](/filings/0001193125-25-266902.md) | [3,156](/filings/0001193125-26-323733.md) | [2,667](/filings/0001193125-26-208946.md) | [2,601](/filings/0001193125-26-323733.md) |
| Shareholders' equity | $m | [2,297](/filings/0000950170-24-123247.md) | [2,300](/filings/0001193125-26-057455.md) | [2,216](/filings/0001193125-25-266902.md) | [2,171](/filings/0001193125-25-266902.md) | [2,104](/filings/0001193125-25-266902.md) | [2,008](/filings/0001193125-26-323733.md) | [1,935](/filings/0001193125-26-323733.md) | [1,757](/filings/0001193125-26-323733.md) | [1,749](/filings/0001193125-25-266902.md) | [1,532](/filings/0001193125-26-323733.md) | [1,493](/filings/0001193125-26-323733.md) | [1,238](/filings/0001193125-26-323733.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.9 d](/filings/0000950170-24-123247.md) | [27.3 d](/filings/0001193125-26-057455.md) | [21.5](/filings/0000950170-25-065829.md) | [5.5 d](/filings/0000950170-25-104004.md) | [39.2 d](/filings/0001193125-25-266902.md) | [18.3 d](/filings/0001193125-26-057455.md) | [(35.8)](/filings/0001193125-26-208946.md) | [(5.8) d](/filings/0001193125-26-323733.md) | [8.8 d](/filings/0001193125-25-266902.md) | [2.4 d](/filings/0001193125-26-057455.md) | [(6.5)](/filings/0001193125-26-208946.md) | [(12.1) d](/filings/0001193125-26-323733.md) |
| Dividends paid | $m | [52.4 d](/filings/0000950170-24-123247.md) | [35.3 d](/filings/0001193125-26-057455.md) | [35.3](/filings/0000950170-25-065829.md) | [35.6 d](/filings/0000950170-25-104004.md) | [35.5 d](/filings/0001193125-25-266902.md) | [14.2 d](/filings/0001193125-26-057455.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [139](/filings/0000950170-23-056882.md) | [138](/filings/0000950170-24-053558.md) | [138](/filings/0000950170-24-090737.md) | [139](/filings/0000950170-24-123247.md) | [139](/filings/0000950170-25-065829.md) | [139](/filings/0000950170-25-104004.md) | [140](/filings/0001193125-25-266902.md) | [139](/filings/0001193125-26-208946.md) | [140](/filings/0001193125-26-323733.md) | [141](/filings/0001193125-25-266902.md) | [140](/filings/0001193125-26-208946.md) | [141](/filings/0001193125-26-323733.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 141,084,206 at 2026-07-28, from the cover of the [10-Q filed 2026-07-29](/filings/0001193125-26-323733.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.